tradingkey.logo

Fulgent Genetics Q4 revenue misses; forecasts about $350 mln in 2026 revenue

ReutersFeb 27, 2026 12:13 PM


Overview

  • Genetic testing firm's Q4 revenue grew 9% yr/yr, missing analyst expectations

  • Adjusted EBITDA loss for Q4 missed analyst expectations

  • Company reported GAAP loss of $23.4 mln, non-GAAP income of $5.2 mln


Outlook

  • Fulgent expects 2026 revenue of approximately $350 mln

  • Company anticipates 2026 non-GAAP loss of approximately ($1.45) per share

  • Fulgent projects cash and investments of approximately $685 mln by end of 2026


Result Drivers

  • LABORATORY SERVICES - Growth driven by momentum in laboratory services and investments in AI and digital pathology

  • THERAPEUTIC DEVELOPMENT - Progress in therapeutic pipeline with FID-007 in Phase 2 and FID-022 in Phase 1

  • OPERATIONAL EFFICIENCIES - Margin improvements due to streamlined operations and enhanced efficiencies


Company press release: ID:nBw5HmR8na


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Miss

$83.34 mln

$85.38 mln (3 Analysts)

Q4 Adjusted EBITDA

Miss

-$4.50 mln

$169,670 (3 Analysts)

Q4 Pretax Profit

Miss

-$29.27 mln

$2.16 mln (2 Analysts)

Q4 Gross Profit

$32.58 mln

Q4 Operating Expenses

$68.82 mln

Q4 Operating Income

-$36.24 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Fulgent Genetics Inc is $35.00, about 41.4% above its February 26 closing price of $24.76


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI